Kenvue Inc. logo KVUE - Kenvue Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 10
SELL 0
STRONG
SELL
0
| PRICE TARGET: $18.25 DETAILS
HIGH: $19.00
LOW: $18.00
MEDIAN: $18.00
CONSENSUS: $18.25
DOWNSIDE: 6.31%

About Kenvue Inc. (https://www.kenvue.com)

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Key Executives

NAME TITLE DOB SALARY
Amit Banati Chief Financial Officer 1969 $7,877,608 USD
Kirk L. Perry Chief Executive Officer & Director 1967 $2,944,089 USD
Meredith Stevens Chief Operations Officer 1963 $1,829,114 USD
Carlton Lawson Group President of Europe, Middle East & Africa 1969 $1,405,623 USD
Matthew Orlando General Counsel 1977 $1,252,895 USD
Michael Wondrasch Chief Technology & Data Officer 1969 $1,019,199 USD
Anil Agarwal Head of Total Rewards
Caroline Tillett Chief Scientific Officer 1972
Heather R. Howlett Interim CFO & Chief Accounting Officer 1978
Jonathan Halvorson Chief Digital & Marketing Officer 1983
Luani Alvarado Chief People Officer 1966
Sofya Tsinis Head of Investor Relations

Company Peers

Peer analysis pending, check back in 1-2 minutes.